KRYSTAL BISCHOFF: Open Payments
NPI 1386258119 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 76 payments from 18 companies in 2025. Trend: 2023 $1,122 · 2024 $1,360 · 2025 $1,333
Food & beverage: $1,333
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $234 |
| E.R. Squibb & Sons, L.L.C. | 22 | $208 |
| Novartis Pharmaceuticals Corporation | 6 | $109 |
| Amgen Inc. | 5 | $101 |
| Merck Sharp & Dohme LLC | 5 | $99 |
| Alnylam Pharmaceuticals Inc. | 3 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79 |
| HEARTFLOW, INC. | 2 | $65 |
| Abbott Laboratories | 2 | $64 |
| United Therapeutics Corporation | 2 | $57 |
Products named: VYNDAQEL, CAMZYOS, ELIQUIS, LEQVIO, REPATHA, AMVUTTRA, JARDIANCE, VERQUVO.
Industry payments across UT — which companies pay providers there.
